Search results for "Left Ventricular Ejection Time"

showing 2 items of 2 documents

Effects of dynamic exercise and metabolic control on left ventricular performance in insulin-dependent diabetes mellitus

1987

In subclinical diabetic cardiomyopathy, previous reports did not positively correlate the altered cardiac performance with metabolic parameters. Fifteen insulin-dependent diabetic subjects, without any clinical or instrumental evidence of heart diseases, were studied. Signs of diabetic microangiopathy were absent. Systolic time intervals, metabolic and hormonal parameters (blood glucose, free fatty acids, blood lactate and plasma norepinephrine) were evaluated at rest and after dynamic exercise during poor (MAGE 6.36 +/- 0.72 mmol/l) and good (MAGE 3.46 +/- 0.66 mmol/l) metabolic control, obtained by means of insulin therapy. Rest values of systolic time intervals were normal during poor an…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPhysical ExertionLeft Ventricular Ejection TimeNorepinephrine (medication)EndocrinologyDiabetes mellitusDiabetic cardiomyopathyInternal medicineInternal MedicinemedicineHumansSubclinical infectionbusiness.industryInsulinHemodynamicsHeartGeneral Medicinemedicine.diseaseDiabetes Mellitus Type 1EndocrinologyMetabolic control analysisHeart Function TestsCardiologyFemalebusinessmedicine.drugHormoneActa Diabetologica Latina
researchProduct

Effects of prostaglandin E1 and buflomedil on left ventricular function in patients with severe chronic occlusive arterial disease: a prospective, ra…

1999

In this study, the effect of a course of prostaglandin E ( 1 ) (60 microg/d intravenously [i.v.]) or buflomedil (150 mg/d i.v.) treatment on parameters of left ventricular systolic function was investigated by echocardiography in patients of comparatively advanced age with severe peripheral occlusive arterial disease (Fontaine's stage III or IV). The study population was 20 patients, 12 men and 8 women, between 51 and 85 years of age (average age, 73. 7 years), with multiple coexisting medical conditions. These patients were no longer suitable candidates for other forms of interventional or surgical treatment. The patients were treated with prostaglandin E ( 1 ) or buflomedil in the dosages…

MalePyrrolidinesDosemedicine.medical_treatmentLeft Ventricular Ejection TimeArterial Occlusive DiseasesVentricular Function Leftchemistry.chemical_compoundDouble-Blind MethodBuflomedilMedicineHumansPharmacology (medical)Prospective StudiesAlprostadilProstaglandin E1Adrenergic alpha-AntagonistsAgedPharmacologyAged 80 and overPeripheral Vascular DiseasesEjection fractionbusiness.industryGeneral MedicineMiddle AgedPeripheralchemistryAnesthesiaChronic DiseasePopulation studyFemalebusinessProstaglandin EAmerican journal of therapeutics
researchProduct